Issued on: 05/02/2026 - 04:23Modified: 05/02/2026 - 04:49

As France 24 marks World Cancer Day, François Picard welcomes Lars Henning Milman Engelholm, Associate Professor and Group Leader at the Finsen Laboratory at the University of Copenhagen. From his lab in Copenhagen, Professor Engelholm describes a seismic shift underway in pancreatic cancer research, the result of a decade-long commitment to the steady evolution of translational science. At the heart of this shift are antibody-drug conjugates (ADCs): highly targeted therapies designed to reach what conventional treatments cannot.

Keywords for this article

Pope Leo says he will undergo surgery for small growth on lung

France: Can the left unite behind a single candidate?

India's 'cockroach' leaders vow to keep up election protests

Strike on Riyadh: What options for the Saudi-led coalition?

Strike on Riyadh: Trump signals US could join action against Houthis

Trump says Ukraine needs new president who will agree to end war

Spain: Sánchez and Feijóo launch campaigns

Trump, Zelensky clash over diesel deal as Russian strikes kill 21

'Going bankrupt': Iran shopkeepers struggle as war dims demand

Trump urges Zelensky replacement as diesel row rages

The content you requested does not exist or is not available anymore.